Quantitative analysis backed by scientific expertise
Bioclinica's cardiovascular expertise is reflected in the form of support for the latest developments in quantitative imaging modalities and endpoints. We offer high quality assessment of cardiovascular images and provide sophisticated image analysis for quantitative cardiovascular measurements in support of novel therapeutics and medical devices. Our partnerships with leading software developers enable the application of cutting edge algorithms for the delivery of high quality quantitative data.
Cardiovascular Imaging Endpoints
Your trial depends on the selection and accurate measurement of cardiovascular endpoints. Our cardiovascular experts have experience with all modalities including the latest advancements in molecular imaging, allowing for an innovative solution for your trial endpoint requirements.
|Echocardiography (ECHO)||Automated contour detection for analysis of segmental wall motion, left ventricular ejection fraction (LVEF), left ventricular mass, end-diastolic and end-systolic volumes|
|Computed Tomography Angiography (CTA)||Measurements of aorta, iliac, and carotid arteries including lumen diameter, percent diameter stenosis, lesion length, and calcium scoring|
|Cardiac Magnetic Resonance Imaging (MRI)||Measurements of global and regional left ventricular function including LVEF, left ventricular mass, wall motion, and wall thickening. Measurements of myocardial perfusion, infarct size and viability.|
|Magnetic Resonance Angiography (MRA)||Analysis of arteriosclerosis and evaluation of MRA contrast agents|
|Positron Emission Tomography (PET)||Analysis of coronary artery disease Myocardial perfusion abnormalities Global and regional function of the ventricles|
|Single Photon Emission Computed Tomography (SPECT)||Analysis of coronary artery disease Myocardial perfusion abnormalities Global and regional function of the ventricle|
|Multiple Gated Acquisition Scan (MUGA)||Measurement of cardiac ejection fractions|